Literature DB >> 11691979

The neurobiology of slow synaptic transmission.

P Greengard1.   

Abstract

Nerve cells communicate with each other through two mechanisms, referred to as fast and slow synaptic transmission. Fast-acting neurotransmitters, e.g., glutamate (excitatory) and gamma-aminobutyric acid (GABA) (inhibitory), achieve effects on their target cells within one millisecond by virtue of opening ligand-operated ion channels. In contrast, all of the effects of the biogenic amine and peptide neurotransmitters, as well as many of the effects of glutamate and GABA, are achieved over hundreds of milliseconds to minutes by slow synaptic transmission. This latter process is mediated through an enormously more complicated sequence of biochemical steps, involving second messengers, protein kinases, and protein phosphatases. Slow-acting neurotransmitters control the efficacy of fast synaptic transmission by regulating the efficiency of neurotransmitter release from presynaptic terminals and by regulating the efficiency with which fast-acting neurotransmitters produce their effects on postsynaptic receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11691979     DOI: 10.1126/science.294.5544.1024

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  280 in total

Review 1.  Aspects of plant intelligence.

Authors:  Anthony Trewavas
Journal:  Ann Bot       Date:  2003-05-09       Impact factor: 4.357

2.  Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors.

Authors:  Lin Pei; Frank J S Lee; Anna Moszczynska; Brian Vukusic; Fang Liu
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

3.  AMPA-sst2 somatostatin receptor interaction in rat hypothalamus requires activation of NMDA and/or metabotropic glutamate receptors and depends on intracellular calcium.

Authors:  Stéphane Peineau; Brigitte Potier; Florence Petit; Pascal Dournaud; Jacques Epelbaum; Robert Gardette
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

4.  Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain.

Authors:  Nelly Khidekel; Scott B Ficarro; Eric C Peters; Linda C Hsieh-Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

5.  Colocalization of somatostatin receptors with DARPP-32 in cortex and striatum of rat brain.

Authors:  Padmesh S Rajput; Geetanjali Kharmate; Ujendra Kumar
Journal:  J Mol Neurosci       Date:  2011-11-25       Impact factor: 3.444

6.  Nerve agent exposure elicits site-specific changes in protein phosphorylation in mouse brain.

Authors:  Hongwen Zhu; Jennifer J O'Brien; James P O'Callaghan; Diane B Miller; Qiang Zhang; Minal Rana; Tiffany Tsui; Youyi Peng; John Tomesch; Joseph P Hendrick; Lawrence P Wennogle; Gretchen L Snyder
Journal:  Brain Res       Date:  2010-04-25       Impact factor: 3.252

Review 7.  Activation of progestin receptors in female reproductive behavior: Interactions with neurotransmitters.

Authors:  Shaila Mani; Wendy Portillo
Journal:  Front Neuroendocrinol       Date:  2010-01-29       Impact factor: 8.606

Review 8.  Glutamatergic model psychoses: prediction error, learning, and inference.

Authors:  Philip R Corlett; Garry D Honey; John H Krystal; Paul C Fletcher
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

9.  Differential effects of the NMDA receptor antagonist MK-801 on dopamine receptor D1- and D2-induced abnormal involuntary movements in a preclinical model.

Authors:  Andrew J Flores; Mitchell J Bartlett; Lisa Y So; Nicholas D Laude; Kate L Parent; Michael L Heien; Scott J Sherman; Torsten Falk
Journal:  Neurosci Lett       Date:  2014-02-11       Impact factor: 3.046

10.  Gene expression differences in mice divergently selected for methamphetamine sensitivity.

Authors:  Abraham A Palmer; Miguel Verbitsky; Rathi Suresh; Helen M Kamens; Cheryl L Reed; Na Li; Sue Burkhart-Kasch; Carrie S McKinnon; John K Belknap; T Conrad Gilliam; Tamara J Phillips
Journal:  Mamm Genome       Date:  2005-05       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.